GlassScriptPhysician profile
Joann Madden
NPI 1497914956
$1,315.21
in general payments reported to CMS, 2019-2025
11 companies · $178 in 2025
The $178 reported for 2025 was less than what a typical Psychiatric/Mental Health, Child & Family provider received nationally (typical 2025 total: $178).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $23.09 · 2022: $289 · 2023: $354 · 2024: $471 · 2025: $178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,003.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,002.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $187.30 | 2022-2023 | Abilify Maintena |
| Janssen Pharmaceuticals, INC | $164.17 | 2024-2025 | Invega Sustenna |
| Alkermes, INC. | $128.21 | 2021-2023 | Lybalvi |
| Abbvie INC. | $125.00 | 2022 | |
| Gilead Sciences, INC. | $124.80 | 2023 | Epclusa |
| Novo Nordisk INC | $112.03 | 2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $107.11 | 2024 | Caplyta |
| Vanda Pharmaceuticals INC. | $106.34 | 2024 | Fanapt |
| Teva Pharmaceuticals USA, INC. | $101.11 | 2022 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $84.61 | 2025 | |
| Viiv Healthcare Company | $74.53 | 2025 | Rukobia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joann Madden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.